270 related articles for article (PubMed ID: 15781586)
1. The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation.
Morinobu M; Nakamoto T; Hino K; Tsuji K; Shen ZJ; Nakashima K; Nifuji A; Yamamoto H; Hirai H; Noda M
J Exp Med; 2005 Mar; 201(6):961-70. PubMed ID: 15781586
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo.
Chikazu D; Li X; Kawaguchi H; Sakuma Y; Voznesensky OS; Adams DJ; Xu M; Hoshio K; Katavic V; Herschman HR; Raisz LG; Pilbeam CC
J Bone Miner Res; 2002 Aug; 17(8):1430-40. PubMed ID: 12162497
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
4. Cnot7-null mice exhibit high bone mass phenotype and modulation of BMP actions.
Washio-Oikawa K; Nakamura T; Usui M; Yoneda M; Ezura Y; Ishikawa I; Nakashima K; Noda T; Yamamoto T; Noda M
J Bone Miner Res; 2007 Aug; 22(8):1217-23. PubMed ID: 17451368
[TBL] [Abstract][Full Text] [Related]
5. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6.
Zachos TA; Shields KM; Bertone AL
J Orthop Res; 2006 Jun; 24(6):1279-91. PubMed ID: 16649180
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a mesenchymal cell line that differentiates into osteoblasts in response to BMP-2 from calvariae of GFP transgenic mice.
Kadowaki A; Tsukazaki T; Hirata K; Shibata Y; Okubo Y; Bessho K; Komori T; Yoshida N; Yamaguchi A
Bone; 2004 Jun; 34(6):993-1003. PubMed ID: 15193545
[TBL] [Abstract][Full Text] [Related]
7. Increased bone morphogenetic protein-6 expression in mouse long bones after estrogen administration.
Plant A; Tobias JH
J Bone Miner Res; 2002 May; 17(5):782-90. PubMed ID: 12009008
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of bone morphogenetic protein/Smad signaling by Cas-interacting zinc finger protein in osteoblasts.
Shen ZJ; Nakamoto T; Tsuji K; Nifuji A; Miyazono K; Komori T; Hirai H; Noda M
J Biol Chem; 2002 Aug; 277(33):29840-6. PubMed ID: 12023967
[TBL] [Abstract][Full Text] [Related]
9. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
[TBL] [Abstract][Full Text] [Related]
10. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
[TBL] [Abstract][Full Text] [Related]
11. Drynariae Rhizoma promotes osteoblast differentiation and mineralization in MC3T3-E1 cells through regulation of bone morphogenetic protein-2, alkaline phosphatase, type I collagen and collagenase-1.
Jeong JC; Lee JW; Yoon CH; Kim HM; Kim CH
Toxicol In Vitro; 2004 Dec; 18(6):829-34. PubMed ID: 15465649
[TBL] [Abstract][Full Text] [Related]
12. Cartilage-derived morphogenetic proteins enhance the osteogenic protein-1-induced osteoblastic cell differentiation of C2C12 cells.
Yeh LC; Tsai AD; Zavala MC; Lee JC
J Cell Physiol; 2004 Dec; 201(3):401-8. PubMed ID: 15389555
[TBL] [Abstract][Full Text] [Related]
13. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
[TBL] [Abstract][Full Text] [Related]
14. Identifying genes that regulate bone remodeling as potential therapeutic targets.
Krane SM
J Exp Med; 2005 Mar; 201(6):841-3. PubMed ID: 15781576
[TBL] [Abstract][Full Text] [Related]
15. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines.
Liu T; Gao Y; Sakamoto K; Minamizato T; Furukawa K; Tsukazaki T; Shibata Y; Bessho K; Komori T; Yamaguchi A
J Cell Physiol; 2007 Jun; 211(3):728-35. PubMed ID: 17226753
[TBL] [Abstract][Full Text] [Related]
16. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.
Morvan F; Boulukos K; Clément-Lacroix P; Roman Roman S; Suc-Royer I; Vayssière B; Ammann P; Martin P; Pinho S; Pognonec P; Mollat P; Niehrs C; Baron R; Rawadi G
J Bone Miner Res; 2006 Jun; 21(6):934-45. PubMed ID: 16753024
[TBL] [Abstract][Full Text] [Related]
17. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
Wu JB; Fong YC; Tsai HY; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jul; 588(2-3):333-41. PubMed ID: 18495116
[TBL] [Abstract][Full Text] [Related]
18. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
[TBL] [Abstract][Full Text] [Related]
19. Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells.
Maeda S; Hayashi M; Komiya S; Imamura T; Miyazono K
EMBO J; 2004 Feb; 23(3):552-63. PubMed ID: 14749725
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of CIZ, a nucleocytoplasmic shuttling protein, prevents unloading-induced bone loss through the enhancement of osteoblastic bone formation in vivo.
Hino K; Nakamoto T; Nifuji A; Morinobu M; Yamamoto H; Ezura Y; Noda M
Bone; 2007 Apr; 40(4):852-60. PubMed ID: 17301008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
